Clinical Pharmacology Exam I

Question 1

When do we want to and not want to induce emesis in our small animal patients?

Answer 1

Question 2

Dogs have more _____ that stimulate CTZ for emesis than cats.

Answer 2

Question 3

Describe apomorphine as an emetic agent used in dogs.

Answer 3

Question 4

Describe ropinirole/clevor as an emetic agent used in dogs.

Answer 4

Question 5

Describe 3% hydrogen peroxide as an emetic agent used in dogs.

Answer 5

Question 6

Vomiting, in the cat, is mediated by ____ in the CTZ.

Answer 6

Question 7

List the different emetic agents we use in cats.

Answer 7

Question 8

Describe capromorelin (entyce) as an appetite stimulate used in dogs. (MOA, adverse effects)

Answer 8

Question 9

Describe mirtazapine as an appetite stimulate used in dogs. (MOA, adverse effects)

Answer 9

Question 10

Describe capromorelin (elura) as an appetite stimulate used in cats. (MOA, adverse effects)

Answer 10

Question 11

Describe cyprogeptadine as an appetite stimulate used in cats. (MOA, adverse effects)

Answer 11

Question 12

Describe mirtazapine (mirtaz) as an appetite stimulate used in cats. (MOA, adverse effects)

Answer 12

Question 13

List the different drug classes of antiemetics we use in veterinary medicine.

Answer 13

Question 14

Name the different phenothiazines we use in veterinary medicine. What are the side effects?

Answer 14

Question 15

Describe the MOA of dopamine receptor antagonists. Name the most come drug used in this class.

Answer 15

Question 16

Describe the use of serotonin receptor antagonists as an antiemetic agent used in veterinary medicine.

Answer 16

Question 17

Describe the MOA, bioavailability, and adverse effects of maropitant (cerenia).

Answer 17

Question 18

So of all the antiemetics agents, which is the best?

Answer 18

Question 19

Describe the indications, MOA, and drugs that are in the acid-titrating drug class.

Answer 19

Question 20

What are the adverse effects and dosing limitations with acid titrating drugs?

Answer 20

Question 21

Describe the MOA and side effects of H2 receptor antagonists. List examples of drugs in this class.

Answer 21

Question 22

How do we use H2 receptor antagonists for EPI patients?

Answer 22

Question 23

What are some adverse effects of H2 receptor antagonists?

Answer 23

Question 24

Describe the MOA of proton pump inhibitors. List some examples of drugs in this class.

Answer 24

Question 25

What are the indicators and adverse effects relative to proton pump inhibitors?

Answer 25

Question 26

What is the MOA of prostaglandin analogs? Name the drug we primarily use in this class.

Answer 26

Question 27

What are the indications and adverse effects of prostaglandin analogs?

Answer 27

Question 28

Describe the MOA and indications for sucralfate.

Answer 28

Question 29

What are the adverse effects and general consensus regarding the use of sucralfate?

Answer 29

Question 30

What are the general guidelines to the use of PPIs?

Answer 30

Question 31

Describe the use of PPIs for gastroduodenal ulcerations and erosions.

Answer 31

Question 32

Describe the use of PPIs for gastritis.

Answer 32

Question 33

Describe the use of PPIs for stress related mucosal damage.

Answer 33

Question 34

Describe the use of PPIs for reflux esophagitis.

Answer 34

Question 35

Describe the use of PPIs for Helicobacter.

Answer 35

Question 36

Describe the MOA, indications, and adverse effects of metronidazole.

Answer 36

Question 37

Describe the MOA, indications, and adverse effects of tylosin.

Answer 37

Question 38

Describe the MOA, indications, and adverse effects of enrofloxacin.

Answer 38

Question 39

Describe the MOA, indications, and adverse effects of suldasalazine.

Answer 39

Question 40

Describe the MOA, indications, and adverse effects of metaclopramide.

Answer 40

Question 41

Describe the MOA, indications, and adverse effects of cisapride.

Answer 41

Question 42

Describe erythromycin as a prokinetic agent.

Answer 42

Question 43

Describe ranitidine and nizatidine as a prokinetic agent.

Answer 43

Question 44

Describe misoprostol as a prokinetic agent.

Answer 44

Question 45

Describe bismuth subsalicylate as a GI protectant/absorbent.

Answer 45

Question 46

Describe activated charcoal as a GI protectant/absorbent.

Answer 46

Question 47

Describe kaolin-pectin as a GI protectant/absorbent.

Answer 47

Question 48

List some of the different laxative and cathartics we use in veterinary medicine.

Answer 48

Question 49

Name some of the different anti-inflammatory drugs used for IBD.

Answer 49

Question 50

Briefly describe the use of probiotics, prebiotics, and synbiotics used in veterinary medicine.

Answer 50